✦ LIBER ✦

Plerixafor Plus Granulocyte Colony-Stimulating Factor versus Placebo Plus Granulocyte Colony-Stimulating Factor for Mobilization of CD34+ Hematopoietic Stem Cells in Patients with Multiple Myeloma and Low Peripheral Blood CD34+ Cell Count: Results of a Subset Analysis of a Randomized Trial

✍ Scribed by Nademanee, Auayporn P.; DiPersio, John F.; Maziarz, Richard T.; Stadtmauer, Edward A.; Micallef, Ivana N.; Stiff, Patrick J.; Hsu, Frank J.; Bridger, Gary; Bolwell, Brian J.

Book ID: 121953333
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 588 KB
Volume: 18
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2012.05.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative Cost-Effectiveness of Plerix

Comparative Cost-Effectiveness of Plerixafor Plus Granulocyte-Colony Stimulating Factor Versus Cyclophosphamide Plus Granulocyte-Colony Stimulating Factor for Autologous Peripheral Blood Stem Cell Mobilization in Patients With Multiple Myeloma

✍ C.J. Campen; A.M. Yeager; M.R. Green; E.P. Armstrong 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Randomized comparison of granulocyte col

Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma

✍ Mukta Arora; Linda J Burns; Juliet N Barker; Jeffrey S Miller; Todd E Defor; Ade 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 184 KB

Comparative Cost-Effectiveness Of Plerix

Comparative Cost-Effectiveness Of Plerixafor Plus Granulocyte-Colony Stimulating Factor Versus Cyclophosphamide Plus Granulocyte-Colony Stimulating For Autologous Peripheral Blood Stem Cell Mobilization In Patients With Non-Hodgkin's Lymphoma

✍ C.J. Campen; E.P. Armstrong; J.A. Christian; S. Hadeed; A.M. Yeager 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 56 KB

A randomized trial comparing the combina

A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products

✍ Sagar Lonial; Michelle Hicks; Hilary Rosenthal; Amelia Langston; Istvan Redei; C 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 246 KB

Mobilization of CD34+ Cells With Granulo

Mobilization of CD34+ Cells With Granulocyte Colony Stimulating Factor (GCSF) Versus Gcsf Plus Plerixafor in Patients With Primary Immunodeficiency Disorders (PIDs) Undergoing Autologous Peripheral Blood Stem Cell (PBSC) Collection

✍ E.M. Kang; Y.Y. Yau; S. Maxwell; S.S. DeRavin; P.D. Borge; H.L. Malech; S.F. Lei 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Beyond CD34+ cell dose: impact of method

Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte–colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit–GM, engraftment, and Day +100 hematopoietic graft function

✍ Erin T. Alexander; Jeanne A. Towery; Ashley N. Miller; Cindy Kramer; Kathy R. Ho 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 212 KB